Weissinger, Eva M. http://orcid.org/0000-0002-5678-3775
Metzger, Jochen
Schleuning, Michael http://orcid.org/0000-0001-8564-4662
Schmid, Christoph
Messinger, Diethelm
Beutel, Gernot
Wagner-Drouet, Eva-Maria
Schetelig, Johannes http://orcid.org/0000-0002-2780-2981
Baurmann, Herrad
Rank, Andreas
Stolzl, Friedrich
Schäfer-Eckart, Kerstin
Westphal, Karin
Bethge, Wolfgang
von Harsdorf, S.
Bunjes, Donald W.
Heidenreich, Daniela
Klein, Stefan
Holler, Ernst
Kreipe, Hans H.
Jonigk, Danny
Türüchanow, Irina
Raad, Julia
Papkalla, Armin
von der Leyen, Heiko
Hambach, Lothar
Hamwi, Iyas
Ehrlich, Steve
Krauter, Jurgen
Stadler, Michael
Ganser, Arnold
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01KG0804, 01KG0804, 01KG0804, 01KG0804, 01KG0804, 01KG0804, 01KG0804, 01KG0804, 01KG0804, 01KG0804, 01KG0804, 01KG0804, 01KG0804, 01KG0804, 01KG0804, 01KG0804, 01KG0804, 01KG0804, 01KG0804, 01KG0804, 01KG0804, 01KG0804, 01KG0804)
employment mosaiques
Jazz Pharmaceuticals
Novartis | Novartis Pharma
Celgene
Incyte: research funding, speakers bureau
Employment Prometris, Mannheim Germany
German Ministry of education and research
Miltenyi Biotec
Neovii: honoraria, research funding
German Ministry of Education and Research
employment mosaiques GmbH
employment Hannover clinical trial center
Article History
Received: 17 June 2020
Revised: 24 August 2020
Accepted: 5 October 2020
First Online: 20 October 2020
Compliance with ethical standards
:
: JM and JR: Mosaiques GmbH, employment. CS: Jazz, membership on an entity’s Board of Directors or advisory committees; Incyte, research funding, speakers bureau; Novartis, research funding, speakers bureau; MoilMed, membership on an entity’s Board of Directors or advisory committees; Celgene, research funding, speakers bureau. DM: Prometris, employment. WB: Miltenyi Biotech GmbH, consultancy, honoraria, research funding; Neovii GmbH, honoraria, research funding. AP and HL: Hannover clinical trial center (HCTC), employment. AG: advisory boards of Jazz Pharmaceuticals, Novartis, and Celgene.